Did management answer the analysts?
12 analyst questions audited, 7 evaded or deflected.
View Claim Ledger →Cyient DLM reported Q4 FY26 revenue of ₹369.1 crore, down 13.8% YoY, impacted by a large order completion in FY25 and West Asia crisis disruptions.
✓ Verified against BSE filing
Cyient DLM reported Q4 FY26 revenue of ₹369.1 crore, down 13.8% YoY, impacted by a large order completion in FY25 and West Asia crisis disruptions. EBITDA margin remained healthy at 11.7%, though down 174 bps YoY. PAT stood at ₹22.4 crore, down 27.6% YoY. The order book reached a record ₹2,416.6 crore, with a book-to-bill ratio of 1.5x, providing strong visibility for FY27. Management highlighted sustained double-digit margins and a robust pipeline of ~$500 million. Key risks include geopolitical uncertainties, tariff overhang on US operations, and potential delays in execution due to supply chain disruptions. The company is investing in sales leadership and build-to-spec capabilities to drive future growth.
12 analyst questions audited, 7 evaded or deflected.
View Claim Ledger →0 delivered, 0 close, 2 missed.
View Promises →West Asia crisis disruption
View Risks →Full transcript text is available on this route.
Read Transcript →Highest order book in last 10 quarters, providing strong revenue visibility for FY27.
Consistent quarterly book-to-bill >1x, indicating sustained demand momentum.
Full-year order intake of $28M, driven by strong traction across key segments.
Management disclosed a pipeline of ~$500M, reflecting strong future order potential.
Management expects to sustain double-digit EBITDA margins, with potential improvement from operating leverage as volumes grow.
Supply chain delays due to West Asia crisis impacted Q4 revenue and inventory levels; risk of continued execution delays.
View Risks →